Lab Glassware

ALL
News
Opinion
Photos
Videos

Jump to

Drugmakers draw more FDA scrutiny as US imports rise

India's drugmakers, battered by a rash of US regulatory rebukes including a record fine for Ranbaxy Laboratories Ltd , face closer FDA scrutiny as the agency ramps up its presence in the country.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Lab Glassware

Drugmakers draw more FDA scrutiny as US imports rise